Predicted Indirectly ReCognizable HLA Epitopes Class I Promote Antileukemia Responses after Cord Blood Transplantation: Indications for a Potential Novel Donor Selection Tool

Biology of Blood and Marrow Transplantation

Volumn 22, Issue 1, 2016, Pages 170-173

  Thus, Kirsten A ^a   de Hoop, Talitha A ^a   de Weger, Roel A ^a   Bierings, Marc B ^a   Boelens, Jaap Jan ^a   Spierings, Eric ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Donor selection; HLA; Indirect recognition; Permissible mismatches; PIRCHE; UCBT

Indexed keywords

HLA ANTIGEN; EPITOPE;

ALGORITHM; ARTICLE; CHILD; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE FREE SURVIVAL; FEMALE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HLA MATCHING; HUMAN; LEUKEMIA RELAPSE; MAJOR CLINICAL STUDY; MALE; MODEL; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTED INDIRECTLY RECOGNIZABLE HLA EPITOPES; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; UNRELATED CORD BLOOD TRANSPLANTATION; ADOLESCENT; ADULT; BLOOD DONOR; DONOR SELECTION; HEMATOLOGIC NEOPLASMS; INFANT; PATHOLOGY; PRESCHOOL CHILD; PROCEDURES; PROSPECTIVE STUDY; SURVIVAL RATE;

ADOLESCENT; ADULT; BLOOD DONORS; CHILD; CHILD, PRESCHOOL; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE-FREE SURVIVAL; DONOR SELECTION; EPITOPES; FEMALE; GRAFT VS LEUKEMIA EFFECT; HEMATOLOGIC NEOPLASMS; HLA ANTIGENS; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84951779104     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2015.08.014     Document Type: Article

References (15)

1. Gragert L., Eapen M., Williams E., et al. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry. N Engl J Med 2014, 371:339-348.
2. Cunha R., Loiseau P., Ruggeri A., et al. Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: a retrospective Eurocord-EBMT analysis. Bone Marrow Transplant 2014, 49:24-29.
3. Sanz J., Jaramillo F.J., Planelles D., et al. Impact on outcomes of human leukocyte antigen matching by allele-level typing in adults with acute myeloid leukemia undergoing umbilical cord blood transplantation. Biol Blood Marrow Transplant 2014, 20:106-110.
4. Atsuta Y., Kanda J., Takanashi M., et al. Different effects of HLA disparity on transplant outcomes after single-unit cord blood transplantation between pediatric and adult patients with leukemia. Haematologica 2013, 98:814-822.
5. Eapen M., Klein J.P., Sanz G.F., et al. Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis. Lancet Oncol 2011, 12:1214-1221.
6. Wagner J.E., Eapen M., Carter S., et al. One-unit versus two-unit cord-blood transplantation for hematologic cancers. N Engl J Med 2014, 371:1685-1694.
7. Eapen M., Klein J.P., Ruggeri A., et al. Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy. Blood 2014, 123:133-140.
8. Hanvesakul R., Maillere B., Briggs D., et al. Indirect recognition of T-cell epitopes derived from the alpha 3 and transmembrane domain of HLA-A2. Am J Transplant 2007, 7:1148-1157.
9. Otten H.G., Calis J.J., Kesmir C., et al. Predicted indirectly recognizable HLA epitopes presented by HLA-DR correlate with the de novo development of donor-specific HLA IgG antibodies after kidney transplantation. Hum Immunol 2013, 74:290-296.
10. Thus K.A., Te Boome L., Kuball J., Spierings E. Indirectly recognized HLA-C mismatches and their potential role in transplant outcome. Front Immunol 2014, 5:210.
11. Thus K.A., Ruizendaal M.T., de Hoop T.A., et al. Refinement of the definition of permissible hla-dpb1 mismatches with Predicted Indirectly ReCognizable HLA-DPB1 epitopes. Biol Blood Marrow Transplant 2014, 20:1705-1710.
12. Lindemans C.A., Chiesa R., Amrolia P.J., et al. Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome. Blood 2014, 123:126-132.
13. van der Harst D., Goulmy E., Falkenburg J.H., et al. Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones. Blood 1994, 83:1060-1066.
14. Molldrem J.J., Lee P.P., Wang C., et al. Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia. Nat Med 2000, 6:1018-1023.
15. Kolb H.J., Schattenberg A., Goldman J.M., et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995, 86:2041-2050.